Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Dry Static Apnoea for Recovery From Acute Laboratory Stress in Trained Breath-Hold Divers

16 november 2026 bijgewerkt door: DeAsís-Fernández, Francisco, Universidad Rey Juan Carlos

Dry Static Apnoea as a Stress-Recovery Strategy: Salivary Cortisol and Heart Rate Variability After Acute Laboratory Stress in Trained Breath-Hold Divers. A Randomized Controlled Trial

This exploratory randomized controlled trial will test whether a short session of dry static apnoea (voluntary breath-holding while lying down, out of the water) helps trained breath-hold divers recover faster from a brief, standardized laboratory stressor than resting for the same amount of time.

Twenty-eight licensed breath-hold divers will attend a single afternoon session of about 85 minutes. All participants first complete the Maastricht Acute Stress Test (alternating immersion of one hand in cold water at about 2 °C with mental arithmetic and negative feedback). They are then randomly assigned to one of two 24-minute conditions: four supervised dry static apnoeas at 50% of their personal best (maximum 3 minutes each), or lying at rest while listening to a neutral informative audio. Both groups then rest until 60 minutes after the start of the stressor.

The main outcome is salivary cortisol 60 minutes after the start of the stressor. Heart rate, heart rate variability, blood pressure, state anxiety and perceived stress will also be compared between groups.

Studie Overzicht

Gedetailleerde beschrijving

Background. Acute stress activates the hypothalamic-pituitary-adrenal axis, which releases cortisol, and the autonomic nervous system, which raises heart rate and reduces vagal tone. For health, how quickly these responses return to baseline matters as much as their magnitude. Slow, controlled breathing increases vagal modulation and is associated with lower anxiety. Voluntary apnoea shares conscious breathing control and additionally triggers a vagally mediated bradycardia (the diving response), which is also present in dry apnoea. Breath-hold divers often report feeling calmer after training, but this has not been tested with objective markers. To avoid the floor effect of afternoon cortisol, a standardized stressor is applied first and the trial then tests whether apnoea accelerates recovery compared with rest. Trained breath-hold divers are studied because they master the technique and do not find it aversive.

Design. Exploratory, two-arm, parallel-group randomized controlled trial with a blinded outcome assessor. Randomization in blocks of 4, stratified by sex. The outcome assessor is unaware of group allocation; the principal investigator delivers the intervention. Sessions take place in the afternoon (arrival between 15:30 and 17:00) to control for the circadian rhythm of cortisol, at the Faculty of Health Sciences, Alcorcón Campus, Universidad Rey Juan Carlos (Madrid, Spain).

Session (about 85 minutes). Baseline rest and recordings; Maastricht Acute Stress Test (5 minutes of instructions and 10 minutes alternating hand immersion in water at about 2 °C with mental arithmetic aloud and negative feedback); 24-minute intervention; rest until 60 minutes after stressor onset; final debriefing.

Interventions. Experimental group: 4 dry static apnoeas in the supine position at 50% of personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas, under continuous supervision. Hyperventilation and lung packing are not allowed. Control group: supine rest for the same duration while listening to a neutral informative audio, previously validated with the Self-Assessment Manikin.

Measurements. Four passive-drool saliva samples (S1 at -7, S2 at +22, S3 at +50 and S4 at +60 minutes relative to stressor onset), stored on ice, frozen at -20 °C and analysed in duplicate by ELISA (Demeditec DES6611). R-R intervals and ECG are recorded with a Polar H10 chest strap and analysed with Kubios HRV; blood pressure with an automatic Omron monitor; SpO2 with a finger pulse oximeter. Validated Spanish questionnaires: PSS-14, STAI-Trait, ASI-3 and MAIA-2 (online screening); STAI-6 and a visual analogue scale of stress (four times during the session); Karolinska Sleepiness Scale (end of session). Descriptive and control variables: age, sex, years of practice and personal best; menstrual cycle phase, sleep, caffeine and physical activity on the day of the session.

Statistical analysis. Cortisol will be log-transformed. Primary analysis: ANCOVA of log(S4) with group as factor and log(S1) and log(S2) as covariates. Complementary analysis: linear mixed model (group x time, S1-S4). Autonomic and subjective outcomes will be analysed in the same way, with Holm correction. Sensitivity analyses: stress responders only; adjustment for menstrual cycle phase and sex. Exploratory moderation analyses: trait anxiety, anxiety sensitivity, interoceptive awareness, chronic perceived stress and the cortisol response to the stressor. Effect sizes with 95% confidence intervals will be reported to inform the sample size of a confirmatory trial.

Sample size. As an exploratory trial, no formal power calculation is performed; following the recommendation of at least 12 participants per group for pilot studies (Julious, 2005), 28 participants (14 per group) will be enrolled to allow for losses.

Safety. Apnoeas are performed dry and lying down, which removes the risk of drowning and falls. Heart rate and SpO2 are monitored continuously and the apnoea is stopped if SpO2 falls below 85% or any symptom appears. Participants may remove the hand from the cold water at any time. A written syncope protocol is in place and a defibrillator is available at the faculty.

Studietype

Ingrijpend

Inschrijving (Geschat)

28

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

  • Naam: Francisco de Asís Fernández Martínez, PhD
  • Telefoonnummer: +34 91 665 50 60
  • E-mail: fasis.fernandez@urjc.es

Studie Locaties

    • Madrid
      • Alcorcón, Madrid, Spanje, 28922
        • Universidad Rey Juan Carlos, Faculty of Health Sciences, Alcorcón Campus
        • Contact:
        • Hoofdonderzoeker:
          • Francisco de Asís Fernández Martínez, PhD

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Age 18 years or older
  • Current breath-hold diving (apnoea) federation licence with insurance
  • Personal best in dry static apnoea of at least 2 minutes

Exclusion Criteria:

  • Cardiovascular, respiratory or endocrine disease, or hypertension
  • Contraindication to cold exposure (e.g., Raynaud's phenomenon)
  • Use of corticosteroids, beta-blockers or psychotropic drugs
  • Smoking
  • Pregnancy
  • Use of hormonal contraceptives
  • Periodontal disease
  • Shift work
  • Previous experience with laboratory stressors

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Fundamentele wetenschap
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Dry static apnoea

Participants complete the Maastricht Acute Stress Test and then perform a 24-minute dry static apnoea session, followed by supine rest until 60 minutes after stressor onset.

Four dry static apnoeas in the supine position, each lasting 50% of the participant's personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas. Hyperventilation and lung packing are not allowed. Continuous supervision by an investigator trained in apnoea and first aid, with heart rate and SpO2 monitoring; the apnoea is stopped if SpO2 falls below 85% or any symptom appears.

Standardized laboratory stressor: 5 minutes of instructions followed by 10 minutes alternating periods of 45-90 seconds with one hand immersed in water at about 2 °C with periods of mental arithmetic aloud with negative feedback. Participants can remove the hand at any time. Debriefing at the end of the session.

Andere namen:
  • MAST
Ander: Passive rest

Participants complete the Maastricht Acute Stress Test and then rest for 24 minutes listening to a neutral audio (time-matched control), followed by supine rest until 60 minutes after stressor onset.

Standardized laboratory stressor: 5 minutes of instructions followed by 10 minutes alternating periods of 45-90 seconds with one hand immersed in water at about 2 °C with periods of mental arithmetic aloud with negative feedback. Participants can remove the hand at any time. Debriefing at the end of the session.

Andere namen:
  • MAST

Supine rest listening through headphones to a neutral informative audio, previously validated as emotionally neutral with the Self-Assessment Manikin. No breathing instructions are given.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Salivary cortisol 60 minutes after stressor onset (S4)
Tijdsspanne: 60 minutes after the start of the stressor (S4), within the single experimental session; samples at 7 minutes before (S1) and 22 minutes after (S2) stressor onset are used as covariates
60 minutes after the start of the stressor (S4), within the single experimental session; samples at 7 minutes before (S1) and 22 minutes after (S2) stressor onset are used as covariates

Secundaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Salivary cortisol across the session
Tijdsspanne: 7 minutes before (S1) and 22 (S2), 50 (S3) and 60 (S4) minutes after stressor onset, within the single experimental session
7 minutes before (S1) and 22 (S2), 50 (S3) and 60 (S4) minutes after stressor onset, within the single experimental session
Heart rate
Tijdsspanne: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Heart rate variability (RMSSD)
Tijdsspanne: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Systolic and diastolic blood pressure
Tijdsspanne: Three measurements during the single experimental session: baseline, after the stressor and at the end of the session (60 minutes after stressor onset)
Three measurements during the single experimental session: baseline, after the stressor and at the end of the session (60 minutes after stressor onset)
State anxiety (STAI-6)
Tijdsspanne: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Perceived stress (visual analogue scale)
Tijdsspanne: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Minimum peripheral oxygen saturation during apnoeas (apnoea group only)
Tijdsspanne: During each of the 4 apnoeas of the 24-minute intervention period
During each of the 4 apnoeas of the 24-minute intervention period
Minimum heart rate during apnoeas (apnoea group only)
Tijdsspanne: During each of the 4 apnoeas of the 24-minute intervention period
During each of the 4 apnoeas of the 24-minute intervention period

Andere uitkomstmaten

Uitkomstmaat
Tijdsspanne
Sleepiness (Karolinska Sleepiness Scale)
Tijdsspanne: End of the single experimental session (60 minutes after stressor onset)
End of the single experimental session (60 minutes after stressor onset)
Number of participants with adverse events
Tijdsspanne: From the start to the end of the single experimental session (about 85 minutes)
From the start to the end of the single experimental session (about 85 minutes)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Francisco de Asís Fernández Martínez, PhD, Universidad Rey Juan Carlos

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

11 januari 2027

Primaire voltooiing (Geschat)

30 april 2027

Studie voltooiing (Geschat)

31 mei 2027

Studieregistratiedata

Eerst ingediend

16 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

16 november 2026

Eerst geplaatst (Werkelijk)

20 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

20 november 2026

Laatste update ingediend die voldeed aan QC-criteria

16 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren